These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12469204)

  • 1. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
    Lau N; Uhlmann EJ; Von Lintig FC; Nagy A; Boss GR; Gutmann DH; Guha A
    Int J Oncol; 2003 Jan; 22(1):195-200. PubMed ID: 12469204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.
    Wienecke R; Maize JC; Reed JA; de Gunzburg J; Yeung RS; DeClue JE
    Am J Pathol; 1997 Jan; 150(1):43-50. PubMed ID: 9006320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Rap1 GTPase in astrocyte growth regulation.
    Apicelli AJ; Uhlmann EJ; Baldwin RL; Ding H; Nagy A; Guha A; Gutmann DH
    Glia; 2003 May; 42(3):225-34. PubMed ID: 12673829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
    Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
    Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.
    Wienecke R; Maize JC; Shoarinejad F; Vass WC; Reed J; Bonifacino JS; Resau JH; de Gunzburg J; Yeung RS; DeClue JE
    Oncogene; 1996 Sep; 13(5):913-23. PubMed ID: 8806680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.
    Geist RT; Reddy AJ; Zhang J; Gutmann DH
    Neurobiol Dis; 1996 Apr; 3(2):111-20. PubMed ID: 9173918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the rap1 signaling pathway are common in human gliomas.
    Gutmann DH; Saporito-Irwin S; DeClue JE; Wienecke R; Guha A
    Oncogene; 1997 Sep; 15(13):1611-6. PubMed ID: 9380414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
    Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant G protein signaling in nervous system tumors.
    Woods SA; Marmor E; Feldkamp M; Lau N; Apicelli AJ; Boss G; Gutmann DH; Guha A
    J Neurosurg; 2002 Sep; 97(3):627-42. PubMed ID: 12296648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
    Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
    Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
    Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
    Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
    Marsh J; Mukherjee P; Seyfried TN
    Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GTPase-activating protein Rap1GAP uses a catalytic asparagine.
    Daumke O; Weyand M; Chakrabarti PP; Vetter IR; Wittinghofer A
    Nature; 2004 May; 429(6988):197-201. PubMed ID: 15141215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
    Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
    Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
    Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA
    In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteins interacting with the tuberous sclerosis gene products.
    Rosner M; Freilinger A; Hengstschläger M
    Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
    Nobukini T; Thomas G
    Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.